A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Clinical trial NCT04986865 · TERMINATED

Trial details

NCT number: NCT04986865
Sponsor: Antengene Biologics Limited
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor Mature B-cell Non-Hodgkin Lymphoma

Start date: 2021-12-15
Primary completion: 2025-01-31
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.